CASI Pharmaceuticals
CASI
#10188
Rank
NZ$28.95 M
Marketcap
NZ$1.41
Share price
14.86%
Change (1 day)
-69.10%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -NZ$81.48 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$26.84 Million. In 2024 the company made an earning of -NZ$63.11 Million a decrease over its 2023 earnings that were of -NZ$43.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$81.48 Million29.1%
2024 -NZ$63.11 Million44.35%
2023 -NZ$43.72 Million-29.55%
2022 -NZ$62.05 Million4.43%
2021 -NZ$59.42 Million-24.56%
2020 -NZ$78.76 Million4.74%
2019 -NZ$75.2 Million65.13%
2018 -NZ$45.54 Million155.07%
2017 -NZ$17.86 Million13.93%
2016 -NZ$15.68 Million31.18%
2015 -NZ$11.95 Million-72.5%
2014 -NZ$43.44 Million356.62%
2013 -NZ$9.52 Million-60.55%
2012 -NZ$24.12 Million218.41%
2011 -NZ$7.58 Million0.74%
2010 -NZ$7.52 Million-32.54%
2009 -NZ$11.15 Million-66.98%
2008 -NZ$33.75 Million-14.22%
2007 -NZ$39.34 Million7.04%
2006 -NZ$36.76 Million27.95%
2005 -NZ$28.73 Million4.51%
2004 -NZ$27.49 Million-15.84%
2003 -NZ$32.66 Million-55.29%
2002 -NZ$73.05 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$84.08 Million31.56%
1999 -NZ$63.91 Million145.56%
1998 -NZ$26.03 Million76.4%
1997 -NZ$14.76 Million36.92%
1996 -NZ$10.78 Million